In fact, the upregulation of Twist and Gro‐α in breast cancer cells treated with thrombin (3.2 and 2.5‐fold increase, respectively) was not observed in the presence of dabigatran (1.5 and 1.4, P = 0.03 for both proteins; Fig. 3A and C). Here, CXCL1 is linked to breast carcinoma.